Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-5524
Authors: Kaps, Leonard
Labenz, Christian
Grimm, Daniel
Schwarting, Andreas
Galle, Peter R.
Schreiner, Oliver
Title: Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection : a case report
Online publication date: 20-Jan-2021
Language: english
Abstract: The biological anakinra appears promising to halt cytokine storm syndrome seen in severe courses of COVID‐19. However, immunosuppression with anakinra may facilitate sepsis, necessitating continuous screening for bacterial superinfections.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
DOI: http://doi.org/10.25358/openscience-5524
Version: Published version
Publication type: Zeitschriftenaufsatz
Document type specification: Scientific article
License: CC-BY
Information on rights of use: https://creativecommons.org/licenses/by/4.0/
Journal: Clinical Case Reports
8
12
Pages or article number: 2989
2993
Publisher: Wiley
Publisher place: Chichester
Issue date: 2020
ISSN: 2050-0904
Publisher's URL: https://doi.org/10.1002/ccr3.3307
Appears in collections:JGU-Publikationen

Files in This Item:
File Description SizeFormat 
kaps_leonard-treatment_of_c-20210104145006284.pdf354.04 kBAdobe PDFView/Open